Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Return on Sales (2023 - 2025)

Camp4 Therapeutics' Return on Sales history spans 3 years, with the latest figure at 34.67% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1430.0% year-over-year to 34.67%; the TTM value through Dec 2025 reached 14.4%, up 6476.0%, while the annual FY2025 figure was 14.46%, 6498.0% up from the prior year.
  • Return on Sales for Q4 2025 was 34.67% at Camp4 Therapeutics, down from 16.64% in the prior quarter.
  • Across five years, Return on Sales topped out at 625.2% in Q3 2024 and bottomed at 144.08% in Q2 2024.
  • The 3-year median for Return on Sales is 15.61% (2025), against an average of 68.73%.
  • The largest YoY upside for Return on Sales was 13568bps in 2025 against a maximum downside of -64184bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 163.36% in 2023, then tumbled by -112bps to 20.37% in 2024, then tumbled by -70bps to 34.67% in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Return on Sales are 34.67% (Q4 2025), 16.64% (Q3 2025), and 8.4% (Q2 2025).